British Society of Blood and Marrow Transplantation and Cellular Therapy

an organisation for those with a professional interest in haematopoietic cell transplantation and cellular therapies

Management of patients with germline predisposition to haematological malignancies considered for allogeneic blood and marrow transplantation: Best practice consensus guidelines from the UK Clinical Genetics Group (UKCGG), CanGene-CanVar, NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group and the British Society of Blood and Marrow Transplantation and cellular therapy (BSBMTCT)

Newsletter

Latest newsletter: January 2022

Select newsletter to download

Platinum Corporate Member

For a list of our gold, silver and bronze corporate members,

click here
© 2023 British Society of Blood and Marrow Transplantation

British Society of Blood and Marrow Transplantation and Cellular Therapies
5th Floor Tabard House, Talbot Yard
Guy's Hospital, Great Maze Pond London.
SE1 9RT United Kingdom

The BSBMTCT is not responsible for the content of external sites

Top